• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Debra Patt on What In-person Attendees Can Expect at the Community Oncology Conference

Video

Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, speaks on the key discussions to be held at the 2022 Community Oncology Conference for in-person attendees.

By bringing together administrators, clinicians, and policy makers within community oncology, in-person attendees at the 2022 Community Oncology Conference can discuss issues facing their respective practices and formulate collaborative solutions, said Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.


Transcript

What can providers and those involved in community oncology gain by being an in-person attendee at the 2022 Community Oncology Conference?

I think that we've all missed seeing each other for the last 2 years, but we've encountered a whole new slew of challenges. The benefit of going to the Community Oncology Alliance meeting is like no other meeting.

It allows you to meet with like-minded individuals that are in community oncology practice—administrators, clinicians, policy makers—and discuss the problems that you've had and formulate collaborative solutions so you can learn from what everyone else is doing. It's a great forum for that and to discuss with people what resources you've developed and share them.

Related Videos
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.